| Increased incidence of venous thromboembolism with cancer immunotherapy J Roopkumar, S Swaidani, AS Kim, B Thapa, L Gervaso, BP Hobbs, ... Med 2 (4), 423-434. e3, 2021 | 82 | 2021 |
| Targeting glutamine metabolism rescues mice from late-stage cerebral malaria EB Gordon, GT Hart, TM Tran, M Waisberg, M Akkaya, AS Kim, ... Proceedings of the National Academy of Sciences 112 (42), 13075-13080, 2015 | 82 | 2015 |
| Mechanisms and biomarkers of cancer-associated thrombosis AS Kim, AA Khorana, KR McCrae Translational Research 225, 33-53, 2020 | 77 | 2020 |
| Toll-like receptor 9 antagonizes antibody affinity maturation M Akkaya, B Akkaya, AS Kim, P Miozzo, H Sohn, M Pena, AS Roesler, ... Nature immunology 19 (3), 255-266, 2018 | 71 | 2018 |
| Venous thromboembolism in cancer patients receiving immunotherapy J Roopkumar, AS Kim, T Bicky, BP Hobbs, AA Khorana Blood, The Journal of the American Society of Hematology 132 (Supplement 1 …, 2018 | 29 | 2018 |
| B cells produce type 1 IFNs in response to the TLR9 agonist CpG-A conjugated to cationic lipids M Akkaya, B Akkaya, P Miozzo, M Rawat, M Pena, PW Sheehan, AS Kim, ... The Journal of Immunology 199 (3), 931-940, 2017 | 27 | 2017 |
| Incidence and clinical pattern of immune related adverse effects (irAE) due to immune checkpoint inhibitors (ICI). B Thapa, J Roopkumar, AS Kim, L Gervaso, PD Patil, C Calabrese, ... Journal of Clinical Oncology 37 (15_suppl), e14151-e14151, 2019 | 24 | 2019 |
| SARS-CoV-2 vaccination and immune thrombotic thrombocytopenic purpura H Shah, A Kim, S Sukumar, M Mazepa, R Kohli, EM Braunstein, ... Blood, The Journal of the American Society of Hematology 139 (16), 2570-2573, 2022 | 16 | 2022 |
| Identifying miRNA biomarkers and predicted targets associated with venous thromboembolism in colorectal cancer patients AS Kim, MF Kalady, J DeVecchio, K Tanriverdi, JE Freedman, J Barnard, ... Blood 134, 3643, 2019 | 8 | 2019 |
| Toll-like receptor 9 signaling antagonizes B cell antigen capture, processing and presentation resulting in a failure to activate helper T cells M Akkaya, B Akkaya, AS Kim, P Miozzo, H Sohn, M Pena, AS Roesler, ... The Journal of Immunology 200 (1_Supplement), 107.1-107.1, 2018 | | 2018 |
| MP49-11 DOES RADIATION EXPOSURE PORTEND WORSE POSTOPERATIVE OUTCOMES AFTER CYSTECTOMY WITH URINARY DIVERSION FOR BENIGN INDICATIONS? P Babbar, A Sun, A Kim, D Hettel, S Agrawal, A Crane, D Sun, R Berglund, ... The Journal of Urology 199 (4S), e670-e670, 2018 | | 2018 |
| Toll-like receptor 9 signaling antagonizes antigen-specific B cell-helper T cell interactions M Akkaya, B Akkaya, AS Kim, P Miozzo, H Sohn, M Pena, J Skinner, ... The Journal of Immunology 198 (1_Supplement), 152.3-152.3, 2017 | | 2017 |
| The Toll-like receptor ligand CpG-A induces type 1 interferons in B cells contrasting the proinflammatory inducing activity of CpG-B M Akkaya, B Akkaya, P Sheehan, P Miozzo, M Rawat, M Pena, AS Kim, ... The Journal of Immunology 198 (1_Supplement), 152.4-152.4, 2017 | | 2017 |
| Closure of Mohs Micrographic Surgery Lower Extremity Wounds: Are We Wasting our Time? S Condon, J Adegboye, A Kim, A Vij American College of Mohs Surgery Annual Meeting, 2017 | | 2017 |
| Toll-like receptor 9 signaling antagonizes the B cell receptor-dependent ability of B cells to process and present antigen to helper T cells. M Akkaya, AS Kim, P Miozzo, HW Sohn, B Akkaya, M Pena, SK Pierce The Journal of Immunology 196 (1_Supplement), 198.6-198.6, 2016 | | 2016 |
| B cells have bifurcated Toll-like receptor signaling allowing both inflammatory cytokine and type 1 interferon responses. M Akkaya, M Rawat, B Akkaya, A Chaturvedi, M Pena, P Miozzo, AS Kim, ... The Journal of Immunology 196 (1_Supplement), 189.18-189.18, 2016 | | 2016 |
| Antigen- and CpG-induced B Cell early signaling events show little synergy AS Kim, M Akkaya, HW Sohn, SK Pierce The Golden Anniversary of B Cell Discovery (X6), 2015 | | 2015 |
| Novel Adjunctive Therapies for Cerebral Malaria That Target Metabolism TM Tran, EB Gordon, GT Hart, M Waisberg, M Akkaya, A Kim, ... Open Forum Infectious Diseases 2 (suppl_1), 1606, 2015 | | 2015 |
